New Zealand markets closed

Spruce Biosciences, Inc. (SPRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7500-0.0199 (-2.58%)
At close: 04:00PM EDT
0.7501 +0.00 (+0.01%)
After hours: 06:06PM EDT
Full screen
Loading interactive chart…
  • Zacks

    Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates

    Spruce Biosciences (SPRB) delivered earnings and revenue surprises of 12.50% and 79.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates

    SOUTH SAN FRANCISCO, Calif., May 13, 2024--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today reported financial results for the first quarter ended March 31, 2024 and provided corporate updates.

  • Business Wire

    Spruce Biosciences to Participate in May Investor Conferences

    SOUTH SAN FRANCISCO, Calif., May 01, 2024--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will participate in two upcoming investor conferences taking place in May.